The diagnostic and prognostic potential of the EGFR/MUC4/MMP9 axis in glioma patients

Keyphrases

• Prognostic Potential 100%
• Diagnostic Potential 100%
• Epidermal Growth Factor Receptor 100%
• Glioma Patients 100%
• MUC4 100%
• Matrix metalloproteinase-9 (MMP-9) 100%
• Glioblastoma 33%
• Protein Level 25%
• Microvasculature 8%
• Clinical Outcomes 8%
• Therapeutic Target 8%
• Poor Prognosis 8%
• Tissue Sampling 8%
• Novel Biomarkers 8%
• Non-invasive Biomarkers 8%
• Immunohistochemistry 8%
• Novel Therapeutics 8%
• Angiogenesis 8%
• Overall Survival 8%
• Enzyme-linked Immunosorbent Assay (ELISA) 8%
• Overexpression 8%
• Putative Drug Targets 8%
• Oncogenesis 8%
• Glioblastoma Progression 8%
• Immunofluorescence 8%
• High-level Expression 8%
• Prognostic Utility 8%
• Brain Cancer 8%
• Fixed Tissue 8%
• Cancer Cell Invasiveness 8%
• Glioma Grading 8%
• Glioma Progression 8%
• Microvascular Proliferation 8%
• Grade III Gliomas 8%
• Kaplan-Meier Survival Analysis 8%

Medicine and Dentistry

• Diagnosis 100%
• Epidermal Growth Factor Receptor 100%
• Ganglioglioma 100%
• Gelatinase B 100%
• Mucin 4 100%
• Glioblastoma 41%
• Biological Marker 16%
• Enzyme Linked Immunosorbent Assay 8%
• Cancer Cell 8%
• Immunohistochemistry 8%
• Cell Invasion 8%
• Angiogenesis 8%
• Microvessel 8%
• Brain Cancer 8%
• Overall Survival 8%
• Carcinogenesis 8%
• Survival Analysis 8%
• Immunofluorescence 8%

Neuroscience

• Epidermal Growth Factor Receptor 100%
• MMP9 100%
• Mucin 4 100%
• Microvessel 8%
• Immunohistochemistry 8%
• Angiogenesis 8%
• Carcinogenesis 8%
• Brain Cancer 8%
• Immunofluorescence 8%
• Cell Invasion 8%
• Survival Analysis 8%